That's the last thing you should want to happen; a buyout by a Big Pharma company like Bayer. However, companies like Google, Amazon, Microsoft, and maybe a few other non-drug firms, IMO, would be better steward for BIEL's fantastic product. The aforementioned are so wealthy, they can fight out any political, or market obstacles. I would be hard pressed to trust a drug company to go hard and heavy to have Actipatch to be a household name, as a non-drug analgesic. Actipatch is a nemesis to them, so why would anyone think they would go all out to promote it, and sustain it? Hey! They just might try to bury it! Well, that's my Take!!
GLTA!!!
News 
Market Data 
Discover 
